Breast Cancer Halted by Novartis Drug From Easter Island

Chemotherapy robbed Rachel Midgett of her hair, appetite and energy as she battled breast cancer that had spread to her liver. After nine months on Novartis AG’s Afinitor, she ran a half-marathon in Las Vegas in December.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.